News
07-08-2008, 09:11 PM
The U.S. Food and Drug Administration has approved a novel genetic test for determining whether patients with breast cancer are good candidates for treatment with the drug Herceptin (trastuzumab).
More... (http://www.news-medical.net/?id=39834)
More... (http://www.news-medical.net/?id=39834)